Haemonetics · 1 day ago
Senior Financial Analyst- Commercial
Boston, MA, US
Full-time
Onsite
Senior Level
$76K/yr - $103K/yr
5+ years expHaemonetics is a dynamic company seeking a Senior Financial Analyst- Commercial to manage resource planning and provide analytical insights. The role involves collaboration with various teams to support financial planning and reporting automation.
BiotechnologyConsultingHealth CareMedicalMedical Device
Responsibilities
Manage resource planning for the Commercial Sales organizations, including tracking current and planned headcount. Leverage Workday and Oracle Workforce Planning to drive forecasting and reporting automation
Collaborate with Commercial Sales, HR, and Finance to ensure alignment of headcount planning
Upload Commercial Sales costs and hiring assumptions to the Workforce Planning forecast system
Collaborate with Commercial teams to build Financial Forecasts, Annual Operating Plan, and Strategic Plans
Collaborate with peers to review sales incentive compensation, particularly for North America and EMEA. Conduct regular audits and reconciliations of commission data to ensure compliance and accuracy
Communicate insights and analysis to various levels of management and sales teams with the goal of providing clarity on drivers of operating performance and impact of key commercial strategies
Support annual sales goals development and analyze/track performance. Work collaboratively with Sales Operations team to accomplish territory goals
Be a thought leader in automation. Leverage tools like Tableau, Power BI, SQL and Databricks to drive automation in reporting and forecasting
Qualification
Required
Bachelor's Degree in Finance, Accounting, or Business
5+ years of experience in Financial Planning and Analysis, including experience with resource planning as well as revenue related analysis
High analytical skills and demonstrated problem-solving and decision-making skills while managing multiple priorities
Must possess strong business analytical skills with thorough understanding of how to identify, interpret, and transform raw data sets into meaningful and actionable solutions
Demonstrated proficiency in using multiple data sources to draw inferences/conclusions and communicate those findings effectively
Drive for accuracy with excellent attention to detail
Ability to organize, prioritize, and deliver within tight deadlines
Strong problem-solving skills
Ability to think strategically coupled with working in a logical and structured way
Open and flexible attitude with the ability to execute tasks within deadlines
Excellent analytical, communication, and organizational skills required
Preferred
Experience in building dashboards using business intelligence tools such as Tableau, Power BI, etc
Advanced knowledge of financial reporting systems (Hyperion/Oracle EPBCS preferred)
Good knowledge of US GAAP
Medical device industry experience
Benefits
401(k) with up to a 6% employer match and no vesting period
An employee stock purchase plan
Flexible time off for salaried employees
For hourly employees, accrual of three to five weeks’ vacation annually (based on tenure)
Accrual of up to 64 hours (annually) of paid sick time
Paid and/or floating holidays
Parental leave
Short- and long-term disability insurance
Tuition reimbursement
Health and welfare benefits
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
1001-5000 employees
H1B Sponsorship
Haemonetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (3)
2022 (2)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Christopher Simon
President and Chief Executive Officer
Christopher Lindop
CFO and VP Business Development
Recent News
2026-01-09
2026-01-03
2025-12-02
Company data provided by crunchbase